The recent shareholding pattern released by Dr Lal Pathlabs Ltd on BSE showed that the insurance giant Life Insurance Corporation of India (LIC) Has taken stake in the healthcare company during the period October-December 2021. Dr Lal Pathlabs shares up over 2% In Thursday’s opening deals, a business of Rs 3,765 was traded on the BSE.
BSE data shows LIC’s name figured in Dr Lal Pathlabs’ December shareholding as it bought 1.12% stake or 9,31,246 equity shares in the diagnostic services provider during the third quarter (Q3) of the current financial year Huh. As of the previous quarter of July-September 2021, the state-owned insurance company and investment giant had no stake in the firm.
On the other hand, mutual funds (MFs) have increased their stake in the company as their stake stands at 3.34% or 27,82,681 shares as of December-end, up from 3.26% or 27,17,883 shares during the second quarter.
Dr Lal Pathlabs shares have gained over 55% in a one-year period, while the stock has gained over 6% in the last six months as compared to a 16% rise in the benchmark Sensex. One of the top diagnostic chains in India, the company has over 5000+ diagnostic tests and related health tests and services for its diagnostic laboratory services.
The company had registered a growth of 10.6% in its consolidated net profit 96 crore for the second quarter ended September 2021 87.1 crore in the year-ago period. Revenue up 15.4% 498.4 crore during the quarter as compared to 431.9 crore in Q2FY21.
Separately, the IPO-bound LIC has bought fresh stake in Tata group company Tata Alexi with 1.04% equity during Q3FY22, BSE data shows.
Never miss a story! Stay connected and informed with Mint.
download
Our App Now!!
,